Sodium glucose co-transporter 2 inhibition: a new avenue to protect the kidney
Author:
Affiliation:
1. Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands
Publisher
Oxford University Press (OUP)
Subject
Transplantation,Nephrology
Link
http://academic.oup.com/ndt/article-pdf/34/12/2015/32567942/gfz033.pdf
Reference18 articles.
1. Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis;Zaccardi;Diabetes Obes Metab,2016
2. Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin;Bolinder;J Clin Endocrinol Metab,2012
3. Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin-angiotensin blockers;Heerspink;Diabetes Obes Metab,2016
4. The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes;Cherney;Diabetologia,2016
5. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fournier’s Gangrene as an Adverse Event Following Treatment with Sodium Glucose Cotransporter 2 Inhibitors;Medicina;2024-05-20
2. Comparison of efficacy and safety of three novel hypoglycemic agents in patients with severe diabetic kidney disease: A systematic review and network meta-analysis of randomized controlled trials;Frontiers in Endocrinology;2022-10-24
3. SGLT2 Inhibitors in Chronic Kidney Disease: From Mechanisms to Clinical Practice;Biomedicines;2022-10-01
4. Effects of SGLT2 inhibitors on haematocrit and haemoglobin levels and the associated cardiorenal benefits in T2DM patients: A meta‐analysis;Journal of Cellular and Molecular Medicine;2021-12-08
5. Obesity and Post-Transplant Diabetes Mellitus in Kidney Transplantation;Journal of Clinical Medicine;2021-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3